Pharmaceutical News

RSS

New 'ETAK Antimicrobial Wet Wipes' for elimination of viruses, bacteria on personal belongings

Eisai Co., Ltd. will launch ETAK( Antimicrobial Wet Wipes (classified as miscellaneous goods) containing long-acting antimicrobial agent ETAK on August 29, 2019 at pharmacies and drugstores countrywide.

From Eisai 29 Aug 2019

Drug combination could improve survival of lung transplant patients

Lung transplantation can prolong the lives of patients with end-stage lung disease, but the median survival rate after lung transplant is less than six years, which has improved only slightly in recent decades.

28 Aug 2019

In India’s burgeoning pain market, U.S. drugmakers stand to gain

Pain, like death, is a universal phenomenon. The sour grimace on the woman's face, registering her bodily complaints to Dr. G.P. Dureja in his East Delhi office, would be recognized anywhere. Slouched shoulders, pinched forehead. She wore a willowy black kurta and cast a disapproving glance at the five pain physicians-in-training huddled behind Dureja, founder of Delhi Pain Management Centre and one of India's pioneering pain physicians.

28 Aug 2019

Medigrowth continues to achieve significant milestones in the Australian cannabis industry

Today, Medigrowth Australia is pleased to provide an update on its activities. Victorian-based Medicinal Cannabis company Medigrowth continues to achieve significant milestones as it navigates a clear path to delivering on its commitment to become a valuable cannabis industry supply chain partner, large scale extraction company and provider of pure, safe and trusted pharmaceutical-grade medical cannabis for delivery to Australian patients.

28 Aug 2019

Study reveals link between popular pain medication and greater risk of hypoglycemia

Since its approval in 1995, the opioid tramadol (marketed as ConZip and Ultram) has become a widely prescribed remedy for osteoarthritis and other painful indications, in part because it presents a lesser risk for some side effects and has a lower abuse potential when compared to other opioids.

28 Aug 2019

Pharma cash rolls into Congress to defend an embattled industry

In the heat of the most ferocious battle over drug prices in years, pharmaceutical companies are showering U.S. senators with campaign cash as sweeping legislation heads toward the floor.

27 Aug 2019

Many drug manufacturers fail to complete the FDA approval process, research reveals

The Food and Drug Administration's Accelerated Approval Program was created in 1992 to significantly accelerate the ability to bring certain new drugs to market.

27 Aug 2019

Out-of-pocket drug costs soar for Medicare patients with multiple sclerosis

Over the course of a decade, out-of-pocket costs for multiple sclerosis drugs rose more than sevenfold for Medicare Part D beneficiaries, according to a JAMA Neurology study published today by researchers at the University of Pittsburgh.

26 Aug 2019

Skin patch delivers melanoma medication in one minute

Researchers have developed a fast-acting skin patch that can deliver medication to treat melanoma in one minute.

26 Aug 2019

Head-to-head comparison of three breast cancer drugs reveals important differences

Every year, more than 250,000 women in the U.S. are diagnosed with breast cancer. When detected early, patients with the most common form--which tests positive for hormone receptors (HR+) and negative for the HER2 receptor--usually respond well to treatment.

23 Aug 2019

Shopping abroad for cheaper medication? Here’s what you need to know

In its effort to temper the sky-high prices Americans pay for many vital medications, the Trump administration last month unveiled a plan that would legalize the importation of selected prescription drugs from countries where they sell for far less.

22 Aug 2019

Research explains why many psychiatric drugs that work in the lab don’t work in people

Current drug development for neuropsychiatric disorders is in crisis, say experts. More than 90 percent of all drugs that are developed for illnesses like schizophrenia, depression, Alzheimer’s disease (AD), or the brain tumor glioblastoma complete successful trials in mice but then come to a grinding halt in human trials, wasting billions of dollars in drug research. This is partly because of obvious behavioral differences between the two species.

22 Aug 2019

FDA clears its IND for new immunotherapeutic for treating prostate cancer

Calibr, the drug development division of Scripps Research, announced today that the U.S. Food and Drug Administration has cleared its investigational new drug application for CCW702, a novel immunotherapeutic for the treatment of patients with metastatic castration-resistant prostate cancer.

21 Aug 2019

Drug that treat human breast cancer might also work for canine lung cancer

Despite those velvet paintings of poker-playing dogs smoking pipes, cigars and cigarettes, our canine friends really don't use tobacco. But like many humans who have never smoked, dogs still get lung cancer.

21 Aug 2019

Dacomitinib treatment for lung cancer increases overall survival but has more side effects

Since its approval in April 2019, dacomitinib has been available for the first-line treatment of adult patients with locally advanced or metastatic non-small cell lung cancer with epidermal growth factor receptor activating mutations.

20 Aug 2019

FDA approves new drug to treat adults with community-acquired bacterial pneumonia

The U.S. Food and Drug Administration today approved Xenleta (lefamulin) to treat adults with community-acquired bacterial pneumonia.

19 Aug 2019

SLU researchers receive $2.1 million to find non-addictive pain medications

Neuropathic pain affects between 15 and 20 million people in the U.S. This type of pain can occur after injuries to the nervous system due to trauma, disease or exposure to neurotoxins, including after chemotherapy.

19 Aug 2019

Researchers find biological system that manages cells' response to opioid drug exposure

A team at Scripps Research in Florida has discovered a biological system that manages cells' response to opioid drug exposure. The unexpected discovery offers new ideas for improving the safety of the one of the most effective, and most abused, group of pain medications.

19 Aug 2019

Hospital pharmacist-led approach can reduce antibiotic use

In small, community hospitals that don't have resources for a dedicated staff to oversee the proper use of antibiotics, turning to staff pharmacists showed promise in a model study conducted by Duke Health.

18 Aug 2019

FDA approves new drug to treat patients with myelofibrosis

Today, the U.S. Food and Drug Administration approved Inrebic (fedratinib) capsules to treat adult patients with certain types of myelofibrosis.

18 Aug 2019

Pharmaceutical News

New 'ETAK Antimicrobial Wet Wipes' for elimination of viruses, bacteria on personal belongings

Drug combination could improve survival of lung transplant patients

In India’s burgeoning pain market, U.S. drugmakers stand to gain

Medigrowth continues to achieve significant milestones in the Australian cannabis industry

Study reveals link between popular pain medication and greater risk of hypoglycemia

Pharma cash rolls into Congress to defend an embattled industry

Many drug manufacturers fail to complete the FDA approval process, research reveals

Out-of-pocket drug costs soar for Medicare patients with multiple sclerosis

Skin patch delivers melanoma medication in one minute

Head-to-head comparison of three breast cancer drugs reveals important differences

Shopping abroad for cheaper medication? Here’s what you need to know

Research explains why many psychiatric drugs that work in the lab don’t work in people

FDA clears its IND for new immunotherapeutic for treating prostate cancer

Drug that treat human breast cancer might also work for canine lung cancer

Dacomitinib treatment for lung cancer increases overall survival but has more side effects

FDA approves new drug to treat adults with community-acquired bacterial pneumonia

SLU researchers receive $2.1 million to find non-addictive pain medications

Researchers find biological system that manages cells' response to opioid drug exposure

Hospital pharmacist-led approach can reduce antibiotic use

FDA approves new drug to treat patients with myelofibrosis

Edoardo Fabini

Reducing polypharmacy through innovative drug formulation technologies

How innovation in dried blood spot testing is transforming neurological disease monitoring

Latest News